Peter Leander
61 – 70 of 78
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2000
-
Mark
Glycogen content in rat liver. Importance for CT and MR imaging
(
- Contribution to journal › Article
-
Mark
MR imaging in clinically suspected acute cholecystitis. A comparison with ultrasonography
(
- Contribution to journal › Article
-
Mark
CT and MR imaging of the liver. Clinical importance of nutritional status
(
- Contribution to journal › Article
- 1999
-
Mark
Image artifacts due to a time-varying contrast medium concentration in 3D contrast-enhanced MRA
(
- Contribution to journal › Article
- 1998
-
Mark
New liposomal liver-specific contrast agent for CT: first human phase I clinical trial assessing efficacy and safety
(
- Contribution to journal › Article
-
Mark
Human pharmacokinetics and modeling of the concentration-attenuation relationship of a new liposomal liver-specific contrast agent for CT
(
- Contribution to journal › Article
- 1996
-
Mark
Liver-specific contrast media for magnetic resonance imaging and computed tomography scanning: importance of contrast media for tumor detection in an experimental liver tumor model
(
- Contribution to journal › Article
-
Mark
CT and MR imaging of the liver using liver-specific contrast media. A comparative study in a tumour model
(
- Contribution to journal › Article
-
Mark
A new liposomal contrast medium for CT of the liver. An imaging study in a rabbit tumour model
(
- Contribution to journal › Article
- 1995
-
Mark
Liver-specific contrast media for MRI and CT experimental studies
(
- Contribution to journal › Article